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ABSTRACT 
In this report, we compared the serum protein electrophoresis (SPE) patterns in a subset 
of HIV-1-infected subjects who did not progress to AIDS without antiretroviral treatment 
with those in whose control of disease progression was achieved by highly active an-
tiretroviral therapy (HAART). SPE and immunofixation electrophoresis were performed 
on Helena Electrophoresis System according to manufacturer’s instructions. The percentage 
of SPE abnormalities, resembling chronic inflammation, was significantly higher in 
HIV-1-infected subject without HAART compared with those under HAART (p = 
0.001). The majority of individuals under HAART showed evidence of oligoclonal bands 
on the γ-band against a polyclonal background compared with those without HAART but 
β-γ-band bridging was more evident. Immunofixation pattern was consistent with oligo-
clonal hypergammaglobulinaemia of IgG kappa type, which was found to be more in-
tense in group without HAART. HIV clinical status did not show appreciable effect on the 
SPE pattern in subjects without HAART. However, under effective HAART, subjects with 
better CD4 T-cell count were associated with higher γ-globulin band. In group without 
HAART, acute infection was found to be associated the higher γ-globulin fraction com-
pared with chronic infection. The opposite was the case under effective HAART. HIV 
infected subjects that did not progress to AIDS were associated with markedly abnormal 
SPE pattern. Overall results reflect the host ability compensate defective cellular immuni-
ty in HIV-1 infection with humoral immune responses. These findings underscore the 
usefulness of SPE monitoring HIV disease management and identifying individuals that 
may not progress to full-blown AIDS in the absence of treatment. 
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INTRODUCTION 
Human immunodeficiency virus type 1 
(HIV-1) selectively infects immune cells, 
thus resulting in depletion of peripheral 
blood CD4 T-lymphocyte population (Post 
et al., 1996, Cloyd et al., 2000). According 
to the joint United Nations Programme on 
HIV/AIDS (UNAIDS) and World Health 
Organization (WHO), 42 million people 
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lived with HIV/AIDS worldwide in year 
2002, resulting in 3 million deaths and ma-
jority of cases occurred in sub-Saharan 
Africa. According to a later report on the 
global AIDS epidemic, 33 million people 
lived with the disease worldwide while 
about 2 million people died in 2007. Recent 
global reports show a decreasing new infec-
tions and AIDS-related deaths. Thus more 
(35 million) people lived with the disease 
in 2010 (UNAID, 2011). Similar trends 
were observed in Nigeria during the period. 
The progression of HIV disease to full-
blown AIDS is usually associated with 
progressive increase in HIV-1 viral load in 
addition to defects in cell-mediated im-
munity. Effective cell-medicated immune 
machinery is therefore found to stem the 
tide of disease progression (Rosenberg et 
al., 1997; Dyer et al., 2008). The rapid re-
duction in AIDS-related mortality and in-
crease in people living with HIV are large-
ly due to the introduction of highly active 
antiretroviral therapy (HAART). HAART 
has been shown to play critical roles in sup-
pressing viral load and increasing CD4+ T 
lymphocyte counts, which translates to sig-
nificant reduced AIDS related morbidity 
and mortality among HIV/AIDS patients 
(Palella et al, 1998; Arminio et al., 2005). 
However, subsets of people living with HIV 
in Nigeria have achieved control over dis-
ease progression without treatment and sim-
ilar observations have been reported in 
therapy-naïve individuals elsewhere (Dyer 
et al., 2008). These observations show that 
lack of HIV disease progression can be in-
dependently obtained with the host’s im-
mune responses and HAART. Viral, genetic 
and immunological factors have been iden-
tified for this phenomenon (Poropatich and 
Sullivan, 2011) and some of the factors 
common with individuals who have been 
exposed to HIV infection but remained un-
infected may also be associated with HIV-
1-infected subjects naïve treatment and yet 
resist progression to AIDS (Lederman et 
al., 2010). 
Unfortunately, none of the identified vi-
ral, genetic and immunological factors is 
routinely investigated to identifying and 
predicting HIV infected individuals that 
may resist progression to AIDS in the ab-
sence of treatment, most especially in re-
sources-poor settings where mere blood 
CD4 T lymphocyte quantity is used to 
qualify candidates for antiretroviral thera-
py. Since all antiretroviral drugs have been 
shown to have both short-term and long-
term adverse reactions (Montessori et al., 
2004), the need to identify HIV-infected 
subjects that would not progress to AIDS 
in the absence of HAART becomes highly 
imperative. In the present research, we 
compared the serum protein electropho-
resis patterns in a subset of HIV-1-infected 
Nigerian subjects who achieved control 
over disease progression without treatment 
with those in whom control of HIV disease 
progression was achieved by HAART, as 
this may reveal the precise usefulness of 
SPE in identifying HIV-infected individuals 
that may not progress to full-blown AIDS 
in the absence of treatment. 
 
MATERIALS AND METHODS 
Selection of subjects 
HIV-1 infected subjects attending Living 
Hope Care, Ilesa, constituted the majority 
of subjects for this study. Others were se-
lected from General Hospital, Iwo and 
Baptist Health Centre Ejigbo, South-western 
Nigeria. Two hundred and sixty (260) sub-
jects were studied. 75 % of selected subjects 
had been receiving effective oral highly 
active antiretroviral therapy (HAART) 
[Lamivudine (300 mg/day), Stavudine (60 
mg/day) and Nevirapine (400 mg/day)] 
while 25 % were not on antiretroviral 
treatment between year 2007 and 2010. In 
the group not on HAART, there was no 
history of AIDS diagnosis including a 
CD4 count < 200 cells/µl, or self-reported 
occurrence of any AIDS-defining illness or 
AIDS diagnosis. Pregnant women and indi-
viduals co-infected with tuberculosis 
and/or hepatitis virus were excluded from 
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the study, because these conditions may ob-
scure or aggravate any potential effect on 
the natural history of HIV disease on serum 
proteins. The HIV-1-infected subjects stud-
ied were asymptomatic and had CD4 T cell 
counts > 200 cells/µl as at the time of en-
rolment. Thirty age-matched apparently 
healthy volunteers were also selected as 
controls. The research was approved by the 
Research Ethics Committee of Living Hope 
Care and informed consent was obtained 
from all subjects. 
 
Diagnosis of HIV Infection and  
enumeration of blood CD4 T-cell 
The diagnosis of HIV-1 infection was 
performed by Enzyme-Linked Immuno-
sorbent Assay (ELISA) and confirmation 
was done by HIV Western Blot using 
Immunetics Qualicode HIV-1/2 Kit (USA). 
Subjects with indeterminate results were 
excluded from the study. Control subjects 
were also confirmed to be HIV sero-
negative. EDTA-anticougulated blood CD4 
T-cell was enumerated using Cyflow® Cy-
tometer according to the manufacturer’s 
instructions (Partec, Germany). 
 
Electrophoresis and immunofixation 
Serum protein electrophoresis was per-
formed using Helena Electrophoresis sys-
tem, according to manufacturer’s instruc-
tions (Beaumont, TX; Sebia, Norcross, 
GA, USA). The electrophoresis gels were 
independently examined by two of the au-
thors (TLO and ALA) and discrepancies 
were resolved by consensus. IFE was per-
formed using commercial kit obtained from 
Bindingsite, Birmingham, United Kingdom. 
The facilities were stored and used accord-
ing to the manufacturer’s instructions. 
 
Densitometry of electrophoregram 
The strip was removed from the final 
rinse tray and excess rinse solution was al-
lowed to drip off into rinse tray. The strip 
was carefully trimmed and immersed in 
40 % aqueous N-methyl pyrolidone for 5 
minutes. Strip was removed from cleaning 
solution and placed lengthwise on a glass 
slide. A second glass was gently pulled 
across the surface at a 45° angle to remove 
xcess fluid and bubbles. The end of strip 
was folded over the edges of the glass slide 
and excess trimmed to about 0.6 cm over-
lap. The slide was placed in an 80-90 °C 
oven for 15 minutes to produce a complete-
ly transparent background. Densitometry 
scanning was performed on a Helena Au-
tomatic Computing Densitometer at 525 
nm according to the manufacturer’s in-
struction (Helena Automatic computing 
Densitometer, Helena Laboratories, Beau-
mont, TX; Sebia, Norcross, GA.USA). 
 
Statistical analysis 
Descriptive analysis, and student t-test 
was used for the comparisons of data. 
Spearman correlation and Fisher’s test were 
used to test association between variables, 
as appropriate, using Graphpad® 5 software 
(San Diego, CA). p-values < 0.05 were con-
sidered significant. 
 
RESULTS 
Study subjects 
HIV-1 infected subjects naïve to 
HAART had a median CD4 lymphocyte 
count of 440 (IQR 321-510) cells/µl while 
that of HIV-1 infected subjects under 
HAART was 410 (IQR 300-605) cells/µl. 
Although, the female to male ratio was 
about 3.3, the blood CD4 T-cell counts of 
the groups were not significantly different 
(p > 0.05). This implies that the HIV-1-
infected subjects studied, HAART-naive 
and treated, had similar clinical status (Table 
1). 
 
Serum protein electrophoresis pattern 
A typical HIV-1 infected subject, in 
this study, regardless of HAART status, 
exhibited a more intense staining at the 
gamma regions of the electrophoregrams 
than healthy HIV-1 uninfected controls. In 
most of the cases studied, increases in 
gamma globulin bands were accompanied 
by apparent decreases in albumin bands. 
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Table 1: Characteristics of study subjects 
CHARACTERISTICS HIV- HAART- HAART+ p-Value 
N 30 65 195  
Age (years) 37 (35, 45) 36 (34, 48) 35 (32, 47) 0.352 
MAC(cm) 28 (24, 29) 29 (28, 30) 27 (25, 31) 0.505 
Body Mass Index (Kgm-2) 24 (22, 25) 24 (21, 26) 25 (22, 27) 0.505 
Sex (M/F) 3/7 7/24 8/23 0.605 
Infection Duration (months) NA 12 (4, 45) 16 (10, 55) 0.236 
HAART Duration (months) NA 0 14 (5, 48) NA 
CD4 T-cell count (/µl) 807 (688, 900) 440 (321, 510) 410 (310, 605) 0.558 
Values are medium (25th and 75th percentile). p-values were determined by Student’s ‘t’ test and 
Fisher’s exact test, as appropriate to compare HAART- and HAART+, p < 0.05 was considered 
significantly different. Not applicable (NA); Mid Arm Circumference (MAC). 
 
Changes in other globulin bands were not 
apparent. It is pertinent to state that some 
of healthy HIV-1-uninfected control studied 
showed mild diffused rise in the -bands 
but with normal albumin band. The HIV-1 
infected subjects were grouped either as 
HAART-treated (HAART+) or without 
HAART (HAART-). Visual examination of 
the electrophoregrams revealed a diffused 
rise in the gamma regions in both groups. 
However, the staining of the gamma re-
gions of group without HAART was con-
sistently more intense than that of 
HAART+ group. Densitometry scanning 
enabled a better appreciation of the behav-
iour of protein fractions. The majority of 
individuals under HAART showed evi-
dence of oligoclonal bands on the γ-band 
against a polyclonal background compared 
with those without HAART but β-γ-band 
bridging was more evident. These features 
were not so obvious on visual examination 
of the electrophoregrams. Densitometry also 
revealed the relative proportions of serum 
protein fractions more clearly. 
To confirm whether the increase in the 
gamma globulin fraction was due to ho-
mogeneous protein, immunofixation elec-
trophoresis was performed on sera suspect-
ed to exhibit homogeneous protein in both 
groups. The patterns obtained were con-
sistent with oligoclonal hypergamma-
globulinaemia of IgG kappa type. The oli-
goclonal IgG κ-banding was found to be 
more intensely stained in subjects without 
HAART (Figure 1). No apparent abnormali-
ty was discovered in 1- and 2-globulin 
bands under effective control of HIV-1 
disease progression. The percentage of SPE 
abnormalities was significantly higher in 
HIV-1 infected subject without HAART 
compared with those under effective 
HAART (p =  0.003). However, the pat-
terns in both groups were consistent with 
chronic inflammation. The summary of 
visual comparison of SPE pattern is shown 
in Table 2. 
 
Effect of clinical status and HAART/infect-
ion duration on SPE pattern 
To ascertain the impact of clinical 
(CD4) status and HAART/infection dura-
tion on the SPE pattern, the subjects were 
divided into sub-groups defined by CD4 T 
lymphocyte counts (< 500 or > 500 cells/ 
µl); and HAART/infection duration: Acute 
(< 12 months) or Chronic (> 36 months). In 
the group without HAART, HIV clinical 
status did not show appreciable effect on 
the SPE pattern. A representative pattern in 
subjects with a CD4 T cells count < 500/ 
µl was found to be essentially similar to 
those with CD4 T-cell count > 500/ul. Un-
der HAART, however, subjects with a bet-
ter clinical status were associated with 
higher γ-globulin bands (Figure 2). In group 
without HAART, acute infection was 
found to be associated the higher γ-globu-
lin fraction compared with chronic infec-
tion. The opposite was true under effective 
HAART. HIV infected subjects that did not 
progress to AIDS were associated with 
markedly abnormal SPE pattern (Figure 3). 
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Table 2: Visual analysis of electrophoresis 
SPE Pattern  HAART- HAART+ p-value 
N  65 195 - 
Normal  16 (25) 90 (46) 0.001 
Abnormal  49(75) 105(54) 0.001 
Albumin ↓ 37(60) 37(19) 0.001 
α1-globulins ↓↑ 0(0) 0(0) 1.000 
α2-globulins ↓↑ 0(0) 0(0) 1.000 
β-globulins ↑ 7(14) 16(8) 0.258 
γ-globulins ↑ 46(71) 96(49) 0.001 
Values are findings (%). p-values were determined by Fisher’s 
test and p < 0.05 was considered significantly different Arrows 
refer to increased (↑), or decreased (↓) regulation. 
 
 
 
HAART- HAART+ 
 
  
 
  
 
  
 
Figure 1: Representative serum protein electrophoresis (SPE) and immunofixation electropho-
resis (IFE) under effective control of HIV-1-diasese progression. Comparison of densitometry 
scans of electrophoregram of HIV-1-infected subject naïve to HAART (HAART-) and under HAART 
(HAART+). SPE was performed under non-denaturing condition in diethylbarbital buffer, pH 8.6 
and visualized with Ponceau S stain. Scanning was performed on a Helena Automatic Computing 
Densitometer at 525nm [Upper panel]. Comparison of IFE of sera from subjects suspected to ex-
hibit homogeneous immunoglobulins (M-protein) of HAART- and HAART+. The gel was visual-
ized with Acid Blue 29 after immunofixation with (left to right) acid fixation (TSP lane); anti-human 
IgG heavy chain(IgG lane); anti-human IgA heavy chain(IgA lane); anti-human IgM heavy chain 
(IgM lane), anti-human kappa light chain (κ lane) and anti-human lambda light chain (λ lane). 
The arrows highlight an oligoclonal IgG κ-banding [Lower panel]. 
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HAART- HAART+ 
 
 
 
 
 
Figure 2: Impact of HIV clinical status on densitometry pattern of serum protein electrophoresis 
(SPE) under effective control of HIV-1-disease progression. Left panel compares the representa-
tive pattern of subjects with CD4 T cell blood count < 500/µl (upper) and > 500/µl (lower) naïve to 
HAART (HAART-) while right panel compares the representative pattern of subjects with CD4 T 
cell blood count < 500/µl (upper) and > 500/µl (lower) under HAART (HAART+). SPE was performed 
under non-denaturing condition using diethylbarbital buffer (pH 8.6) and visualized with Ponceau S 
stain. Densitometry scanning was performed on a Helena Automatic Computing Densitometer at 
525 nm. 
 
 
HAART- HAART+ 
 
 
 
                     Albumin  α1       α2          β                  γ                Albumin  α1       α2           β                  γ 
 
Figure 3: Impact of HAART and infection duration on densitometry pattern of serum protein elec-
trophoresis (SPE) under effective control of HIV-1-disease progression. Left panel compares 
the representative pattern of subjects with acute (upper) and chronic infection (lower) naïve to 
HAART (HAART-) while right panel compares the representative pattern of subjects with acute 
(upper) and chronic infection (lower) under HAART (HAART+). SPE was performed under non-
denaturing condition using diethylbarbital buffer (pH 8.6) and visualized with Ponceau S stain. Den-
sitometry scanning was performed on a Helena Automatic Computing Densitometer at 525 nm. 
 
 
 
 
 Acute
Chronic 
Albumin    α1      α2       β                  γ                 Albumin   α1       α2           β                  γ 
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DISCUSSION 
Previous studies plus personal experi-
ence with support groups for people living 
with HIV/AIDS have shown that control of 
disease progression in HIV-1 infection 
could also be achieved without antiretrovi-
ral chemotherapy (Resino et al., 2003). 
This shows that the host potent HIV specif-
ic and non-specific immunological re-
sponses in individual naïve to treatment 
play crucial roles in control of disease 
progression. Specific and non-specific hu-
moral immune responses can be assessed 
immunological techniques including serum 
protein electrophoresis (SPE). In an earlier 
study, we observed a significant variability 
in the serum protein pattern of subjects in-
fected with HIV-1, even within the same 
clinical (CD4 T-cell count) status (Adedeji 
et al., 2004). It was then speculated that 
individual genetic and intrinsic homeostat-
ic variations (host factors) were responsi-
ble for the phenomenon. Introduction of 
antiretroviral therapy had drastically re-
duced AIDS related mortality in HIV infec-
tion. Since adoption of antiretroviral drugs 
and HAART have altered the outcome 
and prognosis for HIV-infection, we 
sought to study the peculiar association of 
SPE pattern with effective control of HIV 
disease progression and its possible useful-
ness as an adjunct to the standard protocol 
(CD4 T-cell count) in HIV/AIDS control. 
In this study, we specifically compared 
the serum protein electrophoresis pattern of 
HIV-1 infected subjects under effective 
highly active antiretroviral therapy 
(HAART) as well as those latently infected 
but did not progress to AIDS despite ab-
sence of treatment (HAART naïve). The 
majority of the subjects studied were fe-
males (approximately 77 %), either in the 
HAART or HAART naïve group; giving a 
female: male ratio of about 3.3. This may 
imply and support the notion that females 
are more susceptible to HIV-1 infection 
(Glynn et al., 2001). Of course, other factors 
may be responsible for the high female: 
male ratio (Koblin et al, 2000). However, 
others reported a very low female: male 
ratio (about 0.3) in their study population 
(Konstantinopoulos et al., 2007). In this 
study, it was discovered that the HIV-1 in-
fected subjects under effective HAART had 
a higher body mass index (BMI) than the 
HAART naive group. Since the majority of 
subjects in this study were females, the 
higher BMI in the present study is in 
agreement with McDermott et al. (2001) 
who reported a higher BMI in HIV infected 
women under HAART. Stavudine, a com-
posite of HAART in this study is known to 
cause fat redistribution (Gervasoni et al., 
1999) and may contribute to the change in 
BMI. 
Case note information on the subjects 
showed that the individuals in HAART 
group were either in group ‘B’ or ‘C’ of 
the 1993 CDC criteria prior to initiation of 
HAART while the HAART naïve group 
ware in stage ‘A1’ and ‘A2’ (CDC, 1992). 
After effective control of HIV-1 disease 
control however, the HIV-1-infected sub-
jects under HAART had a median CD4 
lymphocyte count 410 cells/µl (IQR 300-
605) which was not significantly different 
(p = 0.427) from those naive to HAART 
[440 cells/µl (IQR 321-510)]. Therefore, 
the subjects in the present study were ap-
parently in group II of the 1986 CDC classi-
fication system for HIV infection (CDC, 
1986). The overall characteristics of HIV-1 
infected subjects under effective highly ac-
tive antiretroviral therapy (HAART) was 
not significantly different (p > 0.05) from 
those latently infected but did not progress 
to AIDS despite absence of treatment. 
SPE separates serum proteins based on 
their physical properties. Cellulose acetate 
and agarose are the widely used as sup-
porting media. Their use permit resolution 
(after staining) of serum proteins into five 
bands designated albumin, alpha-1, alpha-
2, beta and gamma factions respectively. 
The stained strip of cellulose acetate (or 
other supporting medium) is called an elec-
trophoregram. The amount of these five 
bands can be assessed visually and quanti-
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fied by the use of densitometry scanning 
equipment. Characteristic changes in the 
amount of one or more of these five 
bands are found in many diseases (Vav-
ricka et al., 2009). 
The SPE pattern under effective control 
of disease progression was first compared 
with HIV-1-uninfected control. It was dis-
covered that the typical HIV infected sub-
jects under effective control of HIV disease 
had SPE pattern quite different from that of 
the HIV un-infected controls. There was 
diffused rise in the -band leading to a more 
intense staining at the gamma region of the 
electrophoregram implies a higher concen-
tration of -globulin fraction and thus a more 
vigorous humoral immune responses in the 
subjects that did not progress to AIDS in the 
absence of treatment. This was also con-
firmed by the densitometry scanning of the 
electrophoregram. Since serum antibodies 
migrate at the -region, the present work 
supports that of Jacobson et al. (2002) who 
reported higher antibodies concentration in 
HIV-infected subjects compared with HIV-
uninfected controls. The -globulin fraction 
of the electrophoregrams constitutes the 
primary arm of the humoral immune re-
sponses. The persistent abnormally high -
globulin fractions in the face of effective 
control of HIV disease progression suggests 
a compensatory phenomenon for the defi-
cient cellular immunity associated with 
HIV-1 infection. Since HIV is an intracellu-
lar pathogen and adoptive transfer of im-
mune globulin is known to improve quality 
of life of AIDS patients (Durandy et al., 
2009; Onyango-Makumbi et al., 2011), hu-
moral responses would thus have indirect ef-
fects on viral replication. The broad appear-
ance of the -globulin band suggests poly-
clonal responses. This depicts adaptive hu-
moral immune responses not only against 
HIV antigenic determinants but also to pos-
sible complex antigenic epitopes on oppor-
tunistic infectious agents which usually 
contribute to disease progression. Humoral 
responses may also exert direct protective 
action in a number of ways such as re-
cruitment of the complement pathway to 
the destruction or removal of a pathogen. 
Antibody binding to bacterial surfaces may 
promote opsonization, phagocytosis and kill-
ing by macrophages and neutrophils. Vi-
ruses can be bound and neutralized by an-
tibody, even as the antibody marks the 
pathogen for removal from the body by 
phagocytes. By the initiation of antibody-
dependent cell-mediated cytotoxicity, anti-
bodies can also mediate the killing of tar-
get cells by cytotoxic cell populations such 
as natural killer cells (Roitt et al., 1989). 
Possible expression of potent endogenous 
suppressors of HIV such as inhibitors of ser-
ine proteases may also contribute to this 
phenomenon (Shapiro et al., 2001). 
In a healthy individual, the total kappa 
to lambda ratio is roughly 3:1 in serum and 
the ratio may vary widely in pathologic 
conditions such as in HIV infection 
(Katzmann et al., 2002). In this study 
immunofixation electrophoresis confirmed 
that the elevated immunoglobulin was 
mainly due to IgG-kappa especially in 
HAART-naïve group. Although the im-
munofixation pattern did not reveal pres-
ence of IgG-lambda, it does not indicate 
that the subjects sera contained no IgG-
lambda. Rather, it indicates elevated IgG-
kappa as the sera were appropriately diluted 
before immunofixation. This dilution may 
have decreased the serum IgG-lamda be-
low detection. The same explanation may 
also be applicable to IgA and IgM that 
were not demonstrated (Figure 1). 
It is noteworthy that the majority of 
individuals under HAART showed evidence 
of oligoclonal bands on the γ-band against 
a polyclonal background compared with 
HAART-naïve but β-γ-band bridging was 
more evident under HAART-naïve. Oligo-
clonal banding has been reported to be a 
common feature of HIV infection (Ng et 
al., 1988; Tathiah et al., 2011). This is 
likely to be caused by hyperactivation of 
B-cells due to chronic antigenic stimulation 
by antigens of HIV itself or other opportun-
istic infections. Tathiah et al. (2011) have 
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reported increased polyclonal gammopathy 
and oligoclonal bands in HIV infection and 
that the majority of oligoclonal bands 
were present on a background of polyclonal 
gammopathy, suggesting simultaneous pol-
yclonal B-cell activation and selective B-
cell oligoclonal proliferation. This condition 
may have developed before the initiation of 
treatment. IgA migrate at the γ-band but 
very close to β-band (Mayne, 1994) elevat-
ed level of IgA may cause the β-γ-band 
bridging. However, immune-fixation pattern 
did not support elevation serum IgA under 
HAART (Figure 1). 
Changes in other globulin bands were 
not apparent. Significant changes must have 
occurred before there could be obvious 
changes as the case in the -globulin re-
gion. This does not rule out significant 
variation that may have occurred in the 
concentrations of individual globulin frac-
tions. Decrease in albumin fractions often 
accompanies increase in globulin fractions 
in many pathological cases such as in liver 
disease (Vavricka et al., 2009). HIV infec-
tion appears to be also associated with this 
phenomenon in our present study. The in-
creased serum globulins concentration is 
essentially a compensatory mechanism for 
decreased albumin synthesis. It is notewor-
thy that some of healthy HIV-1 uninfected 
control studied showed mild diffuse rise in 
the -band with normal albumin band. Ear-
lier studies speculated that endemicity of 
malaria as a possible reason for higher -
globulins bands in African compared with 
European (Schofield, 1957, Kasper et al, 
1970). Other intrinsic host factors may also 
be responsible as only a minority of appar-
ently normal Nigerians living in Nigeria 
exhibited this relative abnormal electro-
phoresis pattern. The possible intrinsic im-
munologic host factors that may contribute 
to this phenomenon are currently under in-
vestigation in our laboratory. 
Stratification on the basis of HAART/ 
infection duration and HIV clinical status 
added interesting dimensions to the present 
study. We compared the SPE pattern in 
groups defined by the blood CD4 count 
(CD4 <500 or >500/µl). While no apparent 
difference was observed in the densitome-
try pattern in HIV-1-infected subjects na-
ïve to HAART, subjects with better clinical 
status exhibited a higher γ-globulin bands 
under effective HAART. The densitometry 
patterns were remarkable showing evidence 
of oligoclonal bands on the γ-band against 
a polyclonal background. This shows that 
the host ability to resist progression is not 
a function of HIV clinical status in 
HAART naïve subjects. Under effective 
HAART however, improved clinical status 
sequel to treatment enhanced the host abil-
ity to mount humoral immunity against op-
portunistic infections. Without HAART, 
they would normally progress to AIDS and 
the γ-band would decrease and approaches 
a normal pattern as evident in our previous 
work (Adedeji et al, 2004). 
We similarly compared the SPE pattern 
in groups defined by infection and HAART 
duration (Acute or chronic). In this study 
we considered infection duration or 
HAART duration less the 12 months as 
acute while those with greater than 36 
months were considered chronic. It is gen-
erally difficult to estimate the HIV infec-
tion duration precisely (Cohen et al., 
2010, Skar et al., 2013). HIV infection date 
in HAART-naïve subjects was estimated to 
be approximately two months prior the 
date they were first tested positive. Since 
most of them accompanied their spouses to 
hospital on AIDS-related conditions, the 
infection date might even been underesti-
mated. Despite this uncertainty, we dis-
covered that acute infection was associat-
ed the higher γ-globulin band compared 
with chronic infection in HAART-naïve 
subjects. While we were silent on the in-
fection duration before the initiation of 
HAART because of wide variability, we 
were able to estimate HAART duration 
with high degree of certainty as adequate 
treatment records were available. Unlike 
the HAART naïve group, chronic HAART 
was associated with higher γ-globulin band 
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compared with acute treatment. This shows 
that the effectiveness of HAART can be 
estimated from the trend of SPE pattern 
overtime. We were unable to determine the 
viral load to compare the extent of viral 
replication control more importantly in the 
HAART-naïve group. This would have 
enabled us to classify our HAART-naïve 
subjects to either long-term non-progressors 
or elite controllers (Poropatich and Sullivan, 
2011). This would have added a further in-
teresting dimension to the present study. 
In the foregoing, we have shown that 
persistent abnormally high -globulin frac-
tions is associated with effective control of 
HIV disease progression and that humoral 
responses may have indirect effects on vi-
ral replication. Furthermore, the broad ap-
pearance of the -globulin band suggests 
polyclonal responses, not only against HIV 
antigenic determinants but also possible 
complex antigenic epitopes on opportunistic 
infectious agents. Apart from these, we al-
so discovered that the host ability to resist 
progression to AIDS without treatment is 
not a function of HIV clinical status. In 
conclusion, the overall results demonstrate 
the host ability to compensate defective 
cellular immunity with humoral immune 
responses in HIV-1 infection. These find-
ings underscore the usefulness of SPE in 
HIV disease management and identifying 
individuals that may not progress to full-
blown AIDS in the absence of treatment. 
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